HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinico-pharmacologic aspects of therapy with enoximone].

Abstract
Enoximone is an imidazole derivative which proved to be a selective inhibitor of the isoenzymes III/IV of the cAMP-specific phosphodiesterase. It has been shown in various experimental models that the drug exerts both positive inotropic and vasodilating properties which can be attributed to the proposed mode of action. A marked dose-dependent improvement in left ventricular pump performance was observed, with only minor changes in heart rate or systemic blood pressure, if enoximone was administered as i.v. -bolus to patients with moderate to severe congestive heart failure. These effects coincided with vasodilatory effects as determined by decreases in systemic vascular resistance and pulmonary capillary wedge pressure. Enoximone is eliminated by intensive metabolism, predominantly in the liver, with enoximone sulfoxide being the major metabolite in man. Enoximone exhibits a marked firstpass metabolism following oral administration. There is evidence in the literature that the metabolism can be saturated either during long-term administration or by increasing the dose of enoximone. In experimental settings, the metabolite exerts weak positive inotropic effects, too, and reconversion to the parent compound enoximone has been demonstrated in addition. The half-life of elimination of enoximone seems to be about 1 h in healthy volunteers and approximately 3 to 7 h in patients with congestive heart failure, with marked inter-individual differences. In patients with renal failure mainly enoximone sulfoxide accumulates in plasma depending on the degree of renal impairment. The elimination of enoximone seems to be impaired in these patients, too, which might be caused by enhanced reconversion due to the high plasma concentrations of the metabolite.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsD Trenk, E Jähnchen
JournalZeitschrift fur Kardiologie (Z Kardiol) Vol. 83 Suppl 2 Pg. 7-14 ( 1994) ISSN: 0300-5860 [Print] Germany
Vernacular TitleKlinisch-pharmakologische Aspekte der Therapie mit Enoximon.
PMID8091828 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Enoximone
Topics
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Enoximone (administration & dosage, adverse effects, pharmacokinetics)
  • Heart Failure (drug therapy, physiopathology)
  • Hemodynamics (drug effects, physiology)
  • Humans
  • Infusions, Intravenous
  • Metabolic Clearance Rate (physiology)
  • Myocardial Contraction (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: